Spironolactone and hydrochlorothiazide exert antioxidant effects and reduce vascular matrix metalloproteinase-2 activity and expression in a model of renovascular hypertension (2010)
- Authors:
- USP affiliated authors: SALGADO, MARIA CRISTINA DE OLIVEIRA - FMRP ; GERLACH, RAQUEL FERNANDA - FORP ; SANTOS, JOSE EDUARDO TANUS DOS - FMRP
- Unidades: FMRP; FORP
- DOI: 10.1111/j.1476-5381.2010.00678.x
- Subjects: ESTRESSE OXIDATIVO; METALOPROTEINASES; HIPERTENSÃO (TRATAMENTO)
- Language: Inglês
- Imprenta:
- Publisher place: West Sussex
- Date published: 2010
- Source:
- Título: British Journal of Pharmacology
- ISSN: 0007-1188
- Volume/Número/Paginação/Ano: v. 160, n. 1, p. 77-87, 2010
- Este periódico possui versão em assinatura (ou híbrida)
- Este artigo possui versão em acesso aberto
- URL de acesso aberto
- PDF de acesso aberto
- Versão: publishedVersion
- Evidência: deprecated
- Status do Acesso Aberto: bronze
-
ABNT
CERON, C. S. et al. Spironolactone and hydrochlorothiazide exert antioxidant effects and reduce vascular matrix metalloproteinase-2 activity and expression in a model of renovascular hypertension. British Journal of Pharmacology, v. 160, n. 1, p. 77-87, 2010Tradução . . Disponível em: https://doi.org/10.1111/j.1476-5381.2010.00678.x. Acesso em: 10 mar. 2026. -
APA
Ceron, C. S., Castro, M. M., Rizzi, E., Montenegro, M. F., Fontana, V., Salgado, M. C. de O., et al. (2010). Spironolactone and hydrochlorothiazide exert antioxidant effects and reduce vascular matrix metalloproteinase-2 activity and expression in a model of renovascular hypertension. British Journal of Pharmacology, 160( 1), 77-87. doi:10.1111/j.1476-5381.2010.00678.x -
NLM
Ceron CS, Castro MM, Rizzi E, Montenegro MF, Fontana V, Salgado MC de O, Gerlach RF, Tanus-Santos JE. Spironolactone and hydrochlorothiazide exert antioxidant effects and reduce vascular matrix metalloproteinase-2 activity and expression in a model of renovascular hypertension [Internet]. British Journal of Pharmacology. 2010 ; 160( 1): 77-87.[citado 2026 mar. 10 ] Available from: https://doi.org/10.1111/j.1476-5381.2010.00678.x -
Vancouver
Ceron CS, Castro MM, Rizzi E, Montenegro MF, Fontana V, Salgado MC de O, Gerlach RF, Tanus-Santos JE. Spironolactone and hydrochlorothiazide exert antioxidant effects and reduce vascular matrix metalloproteinase-2 activity and expression in a model of renovascular hypertension [Internet]. British Journal of Pharmacology. 2010 ; 160( 1): 77-87.[citado 2026 mar. 10 ] Available from: https://doi.org/10.1111/j.1476-5381.2010.00678.x - Recombinant human matrix metalloproteinase-2 impairs cardiovascular 'beta'-adrenergic responses
- Circulating cell-free DNA levels in plasma increase with severity in experimental acute pulmonary thromboembolism
- The effect of sildenafil on pulmonary embolism-induced oxidative stress and pulmonary hypertension
- Sodium nitrite attenuates MMP-9 production by endothelial cells and may explain similar effects of atorvastatin
- Increased circulating levels of matrix metalloproteinase (MMP)-8, MMP-9, and pro-inflammatory markers in patients with metabolic syndrome
- Nebivolol attenuates prooxidant and profibrotic mechanisms involving TGF-β and MMPs, and decreases vascular remodeling in renovascular hypertension
- Comparative study on antioxidant effects and vascular matrix metalloproteinase-2 downregulation by dihydropyridines in renovascular hypertension
- Nitrite or sildenafil, but not BAY 41-2272, blunt acute pulmonary embolism-induced increases in circulating matrix metalloproteinase-9 and oxidative stress
- Chronic treatment with nebivolol attenuates the vascular changes in the 2-kidney, 1-clip model of renovascular hypertension
- Circulating matrix metalloproteinases and their inhibitors in hypertension
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
